What is the current At-Home COVID-19 Diagnostic Test Kit market size?

The At-Home COVID-19 Diagnostic Test Kit market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the At-Home COVID-19 Diagnostic Test Kit market?

Key drivers include rising COVID-19 cases and growing demand for self-testing kits, driving market growth.

What are the major challenges facing the At-Home COVID-19 Diagnostic Test Kit market?

Major challenges include regulatory hurdles, accuracy concerns, and supply chain disruptions, impacting market growth.

Which regions are leading the At-Home COVID-19 Diagnostic Test Kit market?

North America and Europe are leading the market, driven by high demand and government support.

Who are the top companies in the At-Home COVID-19 Diagnostic Test Kit market?

Top companies include Abbott, Roche, and Becton Dickinson, offering innovative testing solutions.

What are the future opportunities in the At-Home COVID-19 Diagnostic Test Kit market?

Future opportunities include emerging markets, technological advancements, and expanding product portfolios, driving future outlook.

How is technology impacting the At-Home COVID-19 Diagnostic Test Kit market?

Technological advancements are improving test accuracy, speed, and accessibility, transforming the market landscape.

What is the current regulatory landscape for the At-Home COVID-19 Diagnostic Test Kit market?

The regulatory landscape is evolving, with governments implementing guidelines and standards for test kit approval and use.

What Is the Global At-Home COVID-19 Diagnostic Test Kit Market Worth in 2026?

At-Home COVID-19 Diagnostic Test Kit by Application (Antigen Detection, Nucleic Acids Detection), by Types (Nasal Swab, Mid-turbinate Nasal Swab), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $8.1 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $8.1 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

At-Home COVID-19 Diagnostic Test Kit Market Size | CAGR 15.2 Forecast 2033

What Is the Global At-Home COVID-19 Diagnostic Test Kit Market Worth in 2026?

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $8.1 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $8.1 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

At-Home COVID-19 Diagnostic Test Kit Market Overview

The At-Home COVID-19 Diagnostic Test Kit market refers to the global industry of self-administered COVID-19 test kits for personal use. As the world continues to navigate the COVID-19 pandemic, the At-Home COVID-19 Diagnostic Test Kit market size is estimated to be around $4.8 billion in 2025. The growth outlook for this market is promising, with a projected market forecast of $7.8 billion by 2033, driven by the increasing demand for convenient and accurate diagnostic testing solutions. The industry expansion is expected to be fueled by advancements in technology, changes in regulations, and shifting consumer behavior, ultimately driving the market forward with a compound annual growth rate (CAGR) of 8.5%. Key forces shaping the industry include technological shifts towards more accurate and user-friendly test kits, regulatory changes aimed at increasing accessibility and affordability, and competitive intensity among market players.

Loading chart…

The largest region in the At-Home COVID-19 Diagnostic Test Kit market is North America, driven by the high demand for diagnostic testing solutions in the United States. The fastest-growing region is expected to be the Asia-Pacific, fueled by the increasing adoption of at-home diagnostic test kits in countries such as China and India. The market is expected to be shaped by key forces such as technology shifts, regulatory changes, and consumer behavior, ultimately driving the industry towards a more convenient, accurate, and accessible diagnostic testing landscape. With the global pandemic continuing to evolve, the At-Home COVID-19 Diagnostic Test Kit market is poised for significant growth and expansion in the coming years.

Report Overview

Report Attribute	Details
Market size value in 2025	8.10 million
Revenue forecast in 2033	25.12 million
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Celltrion; Lucira Health; Roche Holding; Access Bio; ACON Laboratories; BD; Cue Health; Rapigen Inc; Siemens Healthineer; Detect; Ellume; Genabio Diagnostics; IHealth Labs; InBios International; Maxim Biomedical; OraSure Technologies; OSANG; PHASE Scientific; Quidel Corporation; SD Biosensor; Watmind; Xiamen Boson Biotech; Acon Biotech; Hangzhou AllTest Biotech; Beijing Hotgen Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The At-Home COVID-19 Diagnostic Test Kit market is experiencing significant growth, driven by increasing demand for convenient and accurate testing solutions. The At-Home COVID-19 Diagnostic Test Kit market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Advances in technology have enabled the development of highly sensitive and specific At-Home COVID-19 Diagnostic Test Kits, increasing their adoption among consumers

Government initiatives and regulatory approvals have played a crucial role in driving the growth of the At-Home COVID-19 Diagnostic Test Kit market, with many countries investing heavily in COVID-19 testing infrastructure

Restraints2 items

The high cost of At-Home COVID-19 Diagnostic Test Kits, particularly in low- and middle-income countries, has limited their accessibility and affordability for a significant portion of the population

Concerns regarding the accuracy and reliability of At-Home COVID-19 Diagnostic Test Kits have hindered their widespread adoption, with some studies highlighting the risk of false negatives and false positives

Opportunities2 items

The increasing demand for point-of-care testing solutions has created opportunities for companies to develop innovative At-Home COVID-19 Diagnostic Test Kits that are not only accurate but also user-friendly

The growth forecast of the At-Home COVID-19 Diagnostic Test Kit market is expected to attract new entrants, driving competition and innovation in the market, with a focus on developing cost-effective and highly sensitive testing solutions

Challenges2 items

The At-Home COVID-19 Diagnostic Test Kit market faces significant challenges related to supply chain disruptions, with many manufacturers struggling to meet the surge in demand for testing kits

The lack of standardization in At-Home COVID-19 Diagnostic Test Kits has created challenges for regulatory bodies, making it difficult to ensure the quality and efficacy of these testing solutions

Market Segmentation

Loading chart…

The Application segment of the At-Home COVID-19 Diagnostic Test Kit market refers to the various uses of these test kits, such as self-testing and professional use. This segmentation category contributes to the overall market size by highlighting the different areas where these test kits are utilized, thereby influencing market trends and growth. Understanding the application segment is crucial for companies to develop targeted strategies and cater to specific customer needs, ultimately driving the At-Home COVID-19 Diagnostic Test Kit segmentation.

The Types segment of the At-Home COVID-19 Diagnostic Test Kit market encompasses various subtypes, including [object Object] and [object Object]. This segmentation category plays a significant role in determining the market size, as different types of test kits have distinct characteristics, advantages, and limitations. Analyzing the types segment allows companies to identify areas of opportunity and develop innovative products that address specific customer requirements, further impacting the market taxonomy of the At-Home COVID-19 Diagnostic Test Kit industry.

At-Home COVID-19 Diagnostic Test Kit Segmentation Breakdown6 items

Application

Antigen Detection

Nucleic Acids Detection

Types

Nasal Swab

Mid-turbinate Nasal Swab

Regional Insights

Loading chart…

The At-Home COVID-19 Diagnostic Test Kit market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market share. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of at-home diagnostic kits, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: for North America, demographics and ecosystem maturity; for Europe, policies and infrastructure; for Asia Pacific, adoption and investments; for Latin America, infrastructure and demographics; and for Middle East & Africa, policies and adoption. These factors will contribute to the regional forecast and shape the At-Home COVID-19 Diagnostic Test Kit market.

The regional dynamics will influence the At-Home COVID-19 Diagnostic Test Kit market growth, with each region presenting unique opportunities and challenges. Understanding these regional trends is crucial for stakeholders to navigate the market effectively and make informed decisions.

Competitive Landscape

The At-Home COVID-19 Diagnostic Test Kit market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The At-Home COVID-19 Diagnostic Test Kit competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Companies are focusing on these levers to gain a competitive edge in the market.

Common strategies employed by companies in this market include M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must adapt to these challenges and focus on strategic initiatives.

Abbott: regional expansion

Celltrion: innovation pipeline

Lucira Health: premium pricing

Roche Holding: vertical integration

Access Bio: OEM tie-ups

ACON Laboratories: local manufacturing

Key At-Home COVID-19 Diagnostic Test Kit Companies26 items

Abbott

Celltrion

Lucira Health

Roche Holding

Access Bio

ACON Laboratories

Cue Health

Rapigen Inc

Siemens Healthineer

Detect

Ellume

Genabio Diagnostics

IHealth Labs

InBios International

Maxim Biomedical

OraSure Technologies

OSANG

PHASE Scientific

Quidel Corporation

SD Biosensor

Watmind

Xiamen Boson Biotech

Acon Biotech

Hangzhou AllTest Biotech

Beijing Hotgen Biotech

Market Ecosystem

The At-Home COVID-19 Diagnostic Test Kit ecosystem spans upstream, midstream, and downstream activities, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured as these participants interact to design, manufacture, distribute, and deliver diagnostic test kits to consumers. The ecosystem's boundaries are defined by the flow of goods, services, and information from raw material suppliers to end users, with each participant playing a distinct role in the value chain analysis.

Raw material suppliers — providing components for test kits

OEMs / manufacturers — producing diagnostic test kits

Technology providers — developing testing technologies

Distributors / channel partners — delivering test kits to retailers

Regulators/standards bodies — setting testing standards and approvals

Service providers / after-sales — offering support and maintenance services

End users / buyers — purchasing and using diagnostic test kits

The flow of value through the At-Home COVID-19 Diagnostic Test Kit ecosystem is influenced by control points, such as regulatory approvals and standards, which can create bottlenecks and impact adoption. Dependencies on input supplies, technology advancements, and changing consumer needs also pose risks. Furthermore, switching costs, partnerships, and interoperability requirements can affect the flexibility of participants to respond to changing market conditions. The ecosystem's dynamics can differ by region, with varying regulatory frameworks, market preferences, and distribution channels shaping the interactions among participants.

Recent Industry Insights

The At-Home COVID-19 Diagnostic Test Kit industry has witnessed significant developments over the last 12-18 months, shaping At-Home COVID-19 Diagnostic Test Kit industry trends. Recent partnerships between major pharmaceutical companies and diagnostic kit manufacturers have led to the expansion of product portfolios and enhanced distribution networks. Notable mergers and acquisitions have also taken place, resulting in increased market consolidation and competitiveness.

Additionally, several companies have launched innovative product lines and technologies, focusing on improved test accuracy, user convenience, and affordability. Regulatory changes have also played a crucial role, with updated guidelines influencing the development and approval of at-home diagnostic test kits. Furthermore, a shift in consumer behavior towards self-testing and preventive healthcare has driven demand, while enterprise trends have emphasized the need for reliable and efficient testing solutions. Recent funding rounds and expansions have enabled companies to scale up production and invest in research and development, ultimately driving growth in the At-Home COVID-19 Diagnostic Test Kit market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the At-Home COVID-19 Diagnostic Test Kit market. The At-Home COVID-19 Diagnostic Test Kit market outlook is favorable, driven by increasing demand for convenient and rapid testing solutions. The market attractiveness is high, with a significant potential for growth due to the ongoing COVID-19 pandemic.

The competitive intensity is moderate, with several key players competing for market share. The long-term outlook is positive, with opportunities for innovation and expansion into new markets. However, the demand–supply balance is a key risk factor, as supply chain disruptions and fluctuations in demand can impact market stability. Overall, the At-Home COVID-19 Diagnostic Test Kit market presents a promising opportunity for investors and manufacturers, with a focus on innovation and meeting evolving consumer needs.

11 items

1. Executive Summary

2. At-Home COVID-19 Diagnostic Test Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global At-Home COVID-19 Diagnostic Test Kit Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global At-Home COVID-19 Diagnostic Test Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Antigen Detection

6.1.2. Nucleic Acids Detection

6.2. Global At-Home COVID-19 Diagnostic Test Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Nasal Swab

6.2.2. Mid-turbinate Nasal Swab

6.3. Global At-Home COVID-19 Diagnostic Test Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global At-Home COVID-19 Diagnostic Test Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global At-Home COVID-19 Diagnostic Test Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global At-Home COVID-19 Diagnostic Test Kit Market Competition by Key Manufacturers

8.1. Global At-Home COVID-19 Diagnostic Test Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global At-Home COVID-19 Diagnostic Test Kit: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Celltrion

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Lucira Health

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Roche Holding

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Access Bio

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. ACON Laboratories

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. BD

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Cue Health

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Rapigen Inc

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Siemens Healthineer

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Detect

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Ellume

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Genabio Diagnostics

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. IHealth Labs

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. InBios International

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Maxim Biomedical

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. OraSure Technologies

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. OSANG

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. PHASE Scientific

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Quidel Corporation

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. SD Biosensor

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Watmind

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Xiamen Boson Biotech

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. Acon Biotech

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. Hangzhou AllTest Biotech

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

9.26. Beijing Hotgen Biotech

9.26.1. Company Basic Information and Sales Area

9.26.2. Main Business/Business Overview

9.26.3. Product Portfolio

9.26.4. Financial

9.26.5. Recent Industry Insights

9.26.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global At-Home COVID-19 Diagnostic Test Kit Market

Figure 4: Global At-Home COVID-19 Diagnostic Test Kit Market: Drivers

Figure 5: Global At-Home COVID-19 Diagnostic Test Kit Market: Challenges

Figure 6: Global At-Home COVID-19 Diagnostic Test Kit Market: Trends

Figure 7: Global At-Home COVID-19 Diagnostic Test Kit Market: Opportunity

Figure 8: Global At-Home COVID-19 Diagnostic Test Kit Market: Restraint

Figure 9: Global At-Home COVID-19 Diagnostic Test Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global At-Home COVID-19 Diagnostic Test Kit Market Value (USD Million) By Region

Figure 15: Global At-Home COVID-19 Diagnostic Test Kit Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global At-Home COVID-19 Diagnostic Test Kit Market Value (USD Million) By Region

Figure 23: Global At-Home COVID-19 Diagnostic Test Kit Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

105 items

Table 1: Market Segmentation Analysis

Table 2: Global At-Home COVID-19 Diagnostic Test Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global At-Home COVID-19 Diagnostic Test Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global At-Home COVID-19 Diagnostic Test Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global At-Home COVID-19 Diagnostic Test Kit Market Value (USD Million) By Region

Table 10: Global At-Home COVID-19 Diagnostic Test Kit Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global At-Home COVID-19 Diagnostic Test Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global At-Home COVID-19 Diagnostic Test Kit Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global At-Home COVID-19 Diagnostic Test Kit Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Basic Information And Sales Area

Table 31: Abbott. Products Portfolio

Table 32: Celltrion Basic Information And Sales Area

Table 33: Celltrion. Products Portfolio

Table 34: Lucira Health Basic Information And Sales Area

Table 35: Lucira Health. Products Portfolio

Table 36: Roche Holding Basic Information And Sales Area

Table 37: Roche Holding. Products Portfolio

Table 38: Access Bio Basic Information And Sales Area

Table 39: Access Bio. Products Portfolio

Table 40: ACON Laboratories Basic Information And Sales Area

Table 41: ACON Laboratories. Products Portfolio

Table 42: BD Basic Information And Sales Area

Table 43: BD. Products Portfolio

Table 44: Cue Health Basic Information And Sales Area

Table 45: Cue Health. Products Portfolio

Table 46: Rapigen Inc Basic Information And Sales Area

Table 47: Rapigen Inc. Products Portfolio

Table 48: Siemens Healthineer Basic Information And Sales Area

Table 49: Siemens Healthineer. Products Portfolio

Table 50: Detect Basic Information And Sales Area

Table 51: Detect. Products Portfolio

Table 52: Ellume Basic Information And Sales Area

Table 53: Ellume. Products Portfolio

Table 54: Genabio Diagnostics Basic Information And Sales Area

Table 55: Genabio Diagnostics. Products Portfolio

Table 56: IHealth Labs Basic Information And Sales Area

Table 57: IHealth Labs. Products Portfolio

Table 58: InBios International Basic Information And Sales Area

Table 59: InBios International. Products Portfolio

Table 60: Maxim Biomedical Basic Information And Sales Area

Table 61: Maxim Biomedical. Products Portfolio

Table 62: OraSure Technologies Basic Information And Sales Area

Table 63: OraSure Technologies. Products Portfolio

Table 64: OSANG Basic Information And Sales Area

Table 65: OSANG. Products Portfolio

Table 66: PHASE Scientific Basic Information And Sales Area

Table 67: PHASE Scientific. Products Portfolio

Table 68: Quidel Corporation Basic Information And Sales Area

Table 69: Quidel Corporation. Products Portfolio

Table 70: SD Biosensor Basic Information And Sales Area

Table 71: SD Biosensor. Products Portfolio

Table 72: Watmind Basic Information And Sales Area

Table 73: Watmind. Products Portfolio

Table 74: Xiamen Boson Biotech Basic Information And Sales Area

Table 75: Xiamen Boson Biotech. Products Portfolio

Table 76: Acon Biotech Basic Information And Sales Area

Table 77: Acon Biotech. Products Portfolio

Table 78: Hangzhou AllTest Biotech Basic Information And Sales Area

Table 79: Hangzhou AllTest Biotech. Products Portfolio

Table 80: Beijing Hotgen Biotech Basic Information And Sales Area

Table 81: Beijing Hotgen Biotech. Products Portfolio

Table 82: Global Market Value (USD Million) (2025-2032) By Application

Table 83: Global Market Share (%) By Application (2032)

Table 84: Global Market Value (USD Million) (2025-2032) By Types

Table 85: Global Market Share (%) By Types (2032)

Table 86: Global At-Home COVID-19 Diagnostic Test Kit Market Value (USD Million) By Region

Table 87: Global At-Home COVID-19 Diagnostic Test Kit Market Share (%) By Region (2025-2032)

Table 88: North America Market Value (USD Million) (2025-2032) By Country

Table 89: North America Market Value (USD Million) (2025-2032) By Application

Table 90: North America Market Value (USD Million) (2025-2032) By Types

Table 91: Europe Market Value (USD Million) (2025-2032) By Country

Table 92: Europe Market Value (USD Million) (2025-2032) By Application

Table 93: Europe Market Value (USD Million) (2025-2032) By Types

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 97: South America Market Value (USD Million) (2025-2032) By Country

Table 98: South America Market Value (USD Million) (2025-2032) By Application

Table 99: South America Market Value (USD Million) (2025-2032) By Types

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 103: Research Programs/Design For This Report

Table 104: Key Data Information From Secondary Sources

Table 105: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

At-Home COVID-19 Diagnostic Test Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.10 million
Revenue forecast in 2033	25.12 million
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Celltrion; Lucira Health; Roche Holding; Access Bio; ACON Laboratories; BD; Cue Health; Rapigen Inc; Siemens Healthineer; Detect; Ellume; Genabio Diagnostics; IHealth Labs; InBios International; Maxim Biomedical; OraSure Technologies; OSANG; PHASE Scientific; Quidel Corporation; SD Biosensor; Watmind; Xiamen Boson Biotech; Acon Biotech; Hangzhou AllTest Biotech; Beijing Hotgen Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options